Not investment advice. Educational platform. See Disclaimer.
NASDAQ: APLS
Apellis Pharmaceuticals, Inc.
Healthcare | Biotechnology
Market prices for APLS are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.
EPS (FY2025)$0.20
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 05:59 UTC.
APLS no longer appears among SEC's registered filers -- it may have been acquired, merged, or delisted. The figures on this page reflect the company's final filings and are no longer refreshed.
2019-10-07Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2019-04-12AuditorChanges in registrant's certifying accountantDeloitteEstimatedSEC 8-K →
Apellis Pharmaceuticals, Inc. is a biotechnology company, listed on NASDAQ as APLS.
Where does this data come from?
SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:59 UTC. This page is also available as JSON at /api/data?ticker=APLS and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for APLS and 5,000+ tickers.
Oxford Ledge
Search